Search research articles
Contact Us
Filters
Showing results (351-360 of 426) with videos related to
Page
of 43
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2014
Interrogating two schedules of the AKT inhibitor MK-2206 in patients with advanced solid tumors incorporating novel pharmacodynamic and functional imaging biomarkers
Timothy A Yap, Li Yan, Amita Patnaik, et al.
European Urology
|
March 18, 2014
Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: results from a phase 2 nonrandomized expansion cohort
Ethan Basch, Karen A Autio, Matthew R Smith, et al.
European Urology
|
October 11, 2014
Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)
Nicholas David James, Melissa R Spears, Noel W Clarke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2019
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer
David S Hong, Nicole Concin, Ignace Vergote, et al.
Oncogene
|
May 3, 2019
Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer
Claire E Fletcher, Eric Sulpice, Stephanie Combe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 23, 2020
Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid Tumors
Timothy A Yap, Brent O'Carrigan, Marina S Penney, et al.
European Urology Oncology
|
July 17, 2019
Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis
Pasquale Rescigno, David Dolling, Vincenza Conteduca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2020
Characterizing CDK12-Mutated Prostate Cancers
Pasquale Rescigno, Bora Gurel, Rita Pereira, et al.
European Urology Oncology
|
May 1, 2022
Immune Biomarkers in Metastatic Castration-resistant Prostate Cancer
María Dolores Fenor de la Maza, Khobe Chandran, Jan Rekowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2014
Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study
Matthew R Smith, Christopher J Sweeney, Paul G Corn, et al.
Page
of 43
Search research articles
Search
Showing results (351-360 of 426) with videos related to
Sort By:
Page
of 43
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2014
Interrogating two schedules of the AKT inhibitor MK-2206 in patients with advanced solid tumors incorporating novel pharmacodynamic and functional imaging biomarkers
Timothy A Yap, Li Yan, Amita Patnaik, et al.
European Urology
|
March 18, 2014
Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: results from a phase 2 nonrandomized expansion cohort
Ethan Basch, Karen A Autio, Matthew R Smith, et al.
European Urology
|
October 11, 2014
Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)
Nicholas David James, Melissa R Spears, Noel W Clarke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2019
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer
David S Hong, Nicole Concin, Ignace Vergote, et al.
Oncogene
|
May 3, 2019
Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer
Claire E Fletcher, Eric Sulpice, Stephanie Combe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 23, 2020
Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid Tumors
Timothy A Yap, Brent O'Carrigan, Marina S Penney, et al.
European Urology Oncology
|
July 17, 2019
Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis
Pasquale Rescigno, David Dolling, Vincenza Conteduca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2020
Characterizing CDK12-Mutated Prostate Cancers
Pasquale Rescigno, Bora Gurel, Rita Pereira, et al.
European Urology Oncology
|
May 1, 2022
Immune Biomarkers in Metastatic Castration-resistant Prostate Cancer
María Dolores Fenor de la Maza, Khobe Chandran, Jan Rekowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2014
Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study
Matthew R Smith, Christopher J Sweeney, Paul G Corn, et al.
Page
of 43